Stock Events

Stock Events

Bellevue Group 

€9.15
17
+€0.1+1.1% Today

Statistics

Day High
9.15
Day Low
9.15
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.81%
Dividend
0.17

Upcoming

26
MAR 27
Dividend Ex
Estimated
 
30
MAR 27
Dividend Payment
Estimated
 
27
MAR 28
Dividend Ex
Estimated
 
31
MAR 28
Dividend Payment
Estimated
 

Dividends

1.81%Dividend Yield
Mar 26
€0.16
Mar 25
€0.73
Mar 24
€1.19
Mar 23
€2.01
Mar 22
€2.64
10Y Growth
-15.67%
5Y Growth
-34.25%
3Y Growth
-56.43%
1Y Growth
-77.22%

Earnings

24FebExpected
Q4 2022
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SJZN.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap297.35B
Novartis is a global healthcare company that competes with Bellevue in the pharmaceutical and healthcare investment sectors.
Roche
RHHBY
Mkt Cap322.3B
Roche Holding AG is a major player in the pharmaceuticals and diagnostics market, directly competing with Bellevue's investments in healthcare.
Pfizer
PFE
Mkt Cap153.13B
Pfizer is a leading pharmaceutical company, competing with Bellevue in the healthcare and pharmaceutical investment space.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. is a global healthcare company that competes with Bellevue through its pharmaceutical products and healthcare solutions.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson is a comprehensive healthcare firm that competes across various segments, including pharmaceuticals, medical devices, and consumer health products.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie is a biopharmaceutical company that competes with Bellevue in the healthcare investment sector, particularly in pharmaceuticals.
AMGEN
AMGN
Mkt Cap189.22B
Amgen is a biotechnology firm competing with Bellevue in the biopharmaceutical investment space.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline is a global healthcare company, competing with Bellevue in pharmaceuticals and healthcare products.
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Bristol Myers Squibb is a global biopharmaceutical company, competing with Bellevue in the development and commercialization of pharmaceuticals.
Sanofi
SNY
Mkt Cap113.88B
Sanofi is a global biopharmaceutical company competing with Bellevue in the healthcare and pharmaceutical sectors.

About

Bellevue Group AG provides asset management services for private, corporate, and institutional clients in Switzerland and internationally. The company offers various services in the areas of specialized healthcare equity strategies, alternative investment strategies, and traditional investment strategies. It also provides investment advisory and research services. The company was founded in 1993 and is headquartered in Küsnacht, Switzerland.
Show more...
CEO
Employees
99
Country
Switzerland
ISIN
CH0028422100
WKN
000A0LG3Z

Listings

MU
DE
SJZN.MU
LSE
GB
0QLZ.LSE
F
DE
SJZN.F
SW
CH
BBN.SW

0 Comments

Share your thoughts

FAQ

What is Bellevue Group stock price today?▼
The current price of SJZN.F is €9.15 EUR — it has increased by +1.1% in the past 24 hours. Watch Bellevue Group stock price performance more closely on the chart.
What is Bellevue Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bellevue Group stocks are traded under the ticker SJZN.F.
Does Bellevue Group pay dividends?▼
Yes, SJZN.F dividends are paid annual. The last dividend per share was 0.16 EUR. As of today, Dividend Yield (FWD)% is 1.81%.
How many employees does Bellevue Group have?▼
As of April 15, 2026, the company has 99 employees.
In which sector is Bellevue Group located?▼
Bellevue Group operates in the Finance & Payments sector.
When did Bellevue Group complete a stock split?▼
Bellevue Group has not had any recent stock splits.